The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.

Buda, Alessandro; Casarin, Jvan; Mueller, Michael; Fanfani, Francesco; Zapardiel, Ignacio; Mereu, Liliana; Puppo, Andrea; De Ponti, Elena; Adorni, Marco; Ferrari, Debora; Gasparri, Maria Luisa; Ghezzi, Fabio; Scambia, Giovanni; Papadia, Andrea (2021). The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer. Journal of cancer research and clinical oncology, 147(6), pp. 1599-1606. Springer 10.1007/s00432-020-03435-z

[img] Text
33130942.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (708kB)

PURPOSE

We aimed to assess the impact of low-volume metastasis (micrometastasis and isolated tumor cells) on disease-free survival (DFS) of women with early-stage cervical cancer.

METHODS

Women with clinically suspected stage 1A-IB2 (FIGO 2018 classification) disease who underwent retroperitoneal nodal staging between October 2010 and April 2018, were retrospectively analyzed. The group of women who had undergone lymphadenectomy and standard node pathologic analysis (H&E group), were compared to the group undergoing sentinel node mapping (SLN) and ultrastaging with or without lymphadenectomy (ultrastaging group). At a median follow-up of 45 months, the DFS curves were analyzed.

RESULTS

Overall, 573 patients were revised (272 in the H&E group and 302 in the ultrastaging group). Eighty-five patients presented lymph node metastasis (32 in H&E, 53 in ultrastaging). Ultrastaging protocol increased the rate of low-volume metastasis by 5.6%. Twenty patients showed exclusive micrometastasis or ITC's. Seventy-three recurrences occurred (35 in H&E, 38 in ultrastaging). Only 1 out of 53 patients in the ultrastaging group (1.9%) presented with micrometastasis recurred. The 3-year disease-free survival was 89% for the H&E group, and 88% for the ultrastaging group, respectively (p = 0.175).

CONCLUSION

Ultrastaging analysis allowed increasing the detection of low volume metastasis in women with early-stage cervical cancer. However, the type of nodal staging did not have an impact on patients' 3-year disease-free survival.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Mueller, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1432-1335

Publisher:

Springer

Language:

English

Submitter:

Monika Zehr

Date Deposited:

12 Jan 2021 17:32

Last Modified:

05 Dec 2022 15:43

Publisher DOI:

10.1007/s00432-020-03435-z

Related URLs:

PubMed ID:

33130942

Uncontrolled Keywords:

Cervical cancer Low volume metastases Progression-free survival Sentinel node

BORIS DOI:

10.48350/150106

URI:

https://boris.unibe.ch/id/eprint/150106

Actions (login required)

Edit item Edit item
Provide Feedback